Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: Outcome of a pilot clinical study' by Ning et al

Leukemia

Volumn 23, Issue 1, 2009, Pages 178-

  Behre, G ^a   Theurich, S ^a   Weber, T ^a   Christopeit, M ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ALLOIMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; KARYOTYPE; LETTER; MESENCHYMAL STEM CELL TRANSPLANTATION; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS;

EID: 58249101459     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.150     Document Type: Letter

References (8)

1. Ning H, Yang F, Jiang M, Hu L, Feng K, Zhang J et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study. Leukemia 2008; 22: 593-599.
2. Vianello F, Dazzi F. Mesenchymal stem cells for graft-versus-host disease: A double edged sword? Leukemia 2008; 22: 463-465.
3. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175-181.
4. Klumpp TR. Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood. N Engl J Med 2001; 344: 1641; author reply 2001; 344:1641-1642.
5. Schoch C, Haferlach T, Haase D, Fonatsch C, Loffler H, Schlegelberger B et al. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: A study of 90 patients. Br J Haematol 2001; 112: 118-126.
6. Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer 2005; 43: 227-238.
7. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrorn C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
8. Christopeit M, Schendel M, Foll J, Muller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008; 22: 1062-1064.